Free Weekly Biotech IT Newsletter Want top headlines about Clinical Trial Design & Management, Pharmacovigilance, and Cloud Computing sent straight to your Inbox? Join over 20,000 biotech, pharma and IT professionals who subscribe to FierceBiotechIT for FREE!
FiercePharma's Carly Helfand and FierceBiotech's Damian Garde discuss the discussion around Gilead Sciences' huge cash reserve and the many things the company might buy. Plus, a look back at AbbVie's blockbuster buyout of Pharmacyclics and a consideration of how a certain biotech entrepreneur is bringing attention to an FDA loophole.
FierceBiotechIT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Click here to get your free weekly email briefing today!